Significant Ownership of David E. Lazar

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for David E. Lazar focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ David E. Lazar - David E. Lazar
Manager location
Panama City

Follow Filing Activity

Follow David E. Lazar and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of David E. Lazar

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MYNZ MAINZ BIOMED N.V. Ordinary Shares, (euro)0.01 nominal value 97% 477,000,000 Lazar David E. 22 Apr 2026
INDP Indaptus Therapeutics, Inc. Common Stock, $0.01 par value 48% $949,440 -$50,110,560 2,064,000 -98% Lazar David E. 23 Mar 2026
MINM FiEE, Inc. Common Stock, $0.01 par value 35% $308,248 2,802,254 -63% Lazar David E. 18 Feb 2025
UUU UNIVERSAL SAFETY PRODUCTS, INC. Common Stock, par value $0.01 per share 9.9% $1,809,402 +$803,776 281,400 +80% Lazar David E. 27 Jan 2026
MTNB Matinas BioPharma Holdings, Inc. Common Stock, par value $0.0001 per share 9.8% $517,750 545,000 Lazar David E. 15 Aug 2025
KALA KALA BIO, Inc. Common Stock, $0.001 par value 5.2% $27,522,000 49,500,000 David E. Lazar 30 Jan 2026
NBY NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value 5% $36,028,320 +$27,556,589 6,388,000 +325% David E. Lazar 21 Oct 2025
CYCC Cyclacel Pharmaceuticals, Inc. Common Stock, $0.001 par value 0% $0 -$41,481 0 -100% Lazar David E. 05 Aug 2025

Schedules 13D/G Reported by David E. Lazar:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .